Global licensing · Asia · China
One read both sides can trust.
More molecules now cross borders before they reach patients. A shared read gives the licensor and the buyer the same answer on where the molecule works, in whom, and why.
For the licensor
A read Western buyers can rely on, so the price reflects what the molecule can do, not the discount for distance.
For the buyer
One read you did not have to take on trust. Have it re-run to confirm.
For the adviser
A neutral third-party read that shortens diligence on both sides.
Data stays where it must
Built for the rules on patient data.
China's rules on human genetic resources restrict moving patient genetic data abroad. A market read uses public data only. When a read needs patient data that cannot leave its country, we scope it around that constraint before any data moves.
Scoped case by case · agreed in writing before work begins
Scoping call
In English or Mandarin, through you or your adviser.
NDA
Ours or yours. Company data never enters any other product.
The shared read
Delivered to the licensor; the buyer can have it re-run.
Request received.
A founder will reply within two business days.
Your email app should open with this request. If it didn't, copy it and email it to read@infinitusbio.ai.